Loading...
XKRX
008930
Market cap1.46bUSD
Jul 10, Last price  
33,400.00KRW
1D
2.93%
1Q
-14.14%
Jan 2017
-45.34%
Name

Hanmi Science Co Ltd

Chart & Performance

D1W1MN
XKRX:008930 chart
P/E
19.11
P/S
1.67
EPS
1,748.09
Div Yield, %
0.31%
Shrs. gr., 5y
-0.18%
Rev. gr., 5y
9.62%
Revenues
1.36t
+5.72%
531,396,197,000606,802,686,000689,962,982,000641,470,958,00016,812,302,74019,645,989,150219,862,566,010532,604,690,900776,215,271,160665,284,666,050652,324,367,920707,995,356,120816,618,824,000857,383,419,000950,164,817,0001,046,054,211,0001,247,906,379,0001,283,432,296,0001,356,848,000,000
Net income
118.37b
+99.20%
52,997,718,00071,551,234,00050,526,894,0005,977,013,000-14,690,506,00012,479,133,0009,578,328,00021,312,164,080178,520,883,2207,937,683,00030,068,972,51018,019,525,57030,741,649,00022,601,096,00042,941,996,00069,209,579,000115,121,513,00059,421,641,000118,369,957,000
CFO
47.75b
-42.46%
-16,175,604,00040,923,068,00060,933,793,00036,493,513,000-7,675,597,550-175,636,290-234,788,3005,245,497,90046,927,261,70076,523,442,300-33,681,816,8402,701,370,43013,024,010,00013,817,515,00013,689,812,0009,451,693,00035,158,260,00082,986,394,00047,746,593,000
Dividend
Jun 27, 2025100 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Hanmi Science Co., Ltd. operates through its subsidiaries to produce and distribute pharmaceutical products both within South Korea and internationally. The company's research and development initiatives primarily target treatments for diabetes and various types of cancer. Its extensive product line further includes active pharmaceutical ingredients, general therapeutic drugs, nutritional supplements, and a variety of health-related goods and services. Additionally, it manages an online pharmacy platform and provides automated systems for pharmaceutical administration. The firm, which was initially established as Hanmi Holdings Co., Ltd. in 1973, adopted its current name, Hanmi Science Co., Ltd., in March 2012, and its corporate headquarters are situated in Seoul, South Korea.
URL
http://www.hanmiscience.co.kr/
IPO date
Jun 20, 1988
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT